Cornea

A five-step approach to personalise and simplify treatment, leading to higher efficacy

Ophthalmologists report that dry eye syndrome, myopia progression and other ocular pathologies have increased, especially among paediatric patient groups

Nordic Pharma plans to announce commercialisation details in the near future for the dry eye disease treatment

Aldeyra previously received a CRL for its initial New Drug Application for reproxalap in November 2023

AURN001 is Aurion Biotech's clinical-stage allogeneic cell therapy asset for corneal oedema secondary to corneal endothelial disease

The authors examined vascular and neural structures in the eye, assessing the foveal avascular zone and choroidal thickness

The Arise system utilises advanced algorithms to interpret corneal topography images, recommending lenses without requiring a fitting set

Prophylactic cyclosporine A 0.1% eye drops were associated with improved ocular surface homeostasis and reduced inflammation

A large-scale study indicates women are more likely to develop the inherited corneal condition

Urcosimod, formerly known as OK-101, showed clear statistical significance in multiple endpoints in a recently completed Phase 2 trial

The authors said their results provide strong support that cultivated autologous limbal epithelial cell transplantation is safe and feasible

The authors emphasised that consumers and clinicians should be made aware of potential ophthalmic adverse events associated with cosmetics and personal care products

A qualitative study method illuminates patients’ fears for the future

A case report highlights the pathogen’s potential to cause severe, devastating ocular infections, despite aggressive treatment

Highlights from the year, courtesy of our colleagues at Ophthalmology Times

Trending topics and milestone stories from our year in ophthalmology

Our top 10 print stories highlight the core content concepts we explored this year

Low-level light therapy for dry eye disease and chalazion

Espansione Group's Light Modulation Low-level Light Therapy (LLLT) is used in ophthalmology and dermatology

The authors analysed severity and frequency of ocular pain among patients with DED living in altitudes above 2,500 meters during the COVID-19 pandemic

The incidence was comparable to that of daily wear soft contact lenses

Assessing two devices in a real-world setting

Investigators from Bergen, Norway, and Cleveland, Ohio, collaborated on the predictive model

The authors reported significant variability in DED-related symptoms, with higher prevalence rates among university students and administrative workers

Farhad Hafezi, FARVO, MD, PhD, and colleagues reported on results achieved with phototherapeutic keratectomy-assisted, customised, epi-on corneal crosslinking

Dry eye increases susceptibility to psychiatric disorders and chronic pain syndromes, investigators reported at the 2024 AAO meeting

Ciclosporin 0.1% eye drops solution will be marketed under the brand name Vevizye in the EU for the treatment of dry eye disease

Current and future options for Fuchs endothelial corneal dystrophy

Neltependocel has received both regulatory and reimbursement approval in Japan

Michael Goldstein, MD, discusses 12-month safety and efficacy trial data of human corneal endothelial cell therapy, presented at the 2024 ESCRS Congress